FLNA — Filana Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Filana Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.4 | -76.2 | -97.2 | -24.3 | -91 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.76 | 2.07 | 4.59 | -91.9 | 19.6 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.104 | -4.63 | 9.08 | -1.83 | 38.2 |
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -30.2 | -77.5 | -82 | -117 | -32.3 |
| Capital Expenditures | -22.2 | -2.71 | -0.414 | -0.103 | -0.581 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -22.2 | -2.71 | -0.414 | -0.103 | -0.581 |
| Financing Cash Flow Items | — | — | — | — | -0.329 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 192 | 47.8 | 2.56 | 124 | -0.239 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 140 | -32.4 | -79.9 | 7.44 | -33.1 |